首页> 美国卫生研究院文献>Mediators of Inflammation >Influence of Epinastine Hydrochloride an H1-Receptor Antagonist on the Function of Mite Allergen-Pulsed Murine Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo
【2h】

Influence of Epinastine Hydrochloride an H1-Receptor Antagonist on the Function of Mite Allergen-Pulsed Murine Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo

机译:盐酸Epinastine H1受体拮抗剂对螨过敏原刺激的鼠骨髓骨髓树突状细胞功能的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There is established concept that dendritic cells (DCs) play essential roles in the development of allergic immune responses. However, the influence of H1 receptor antagonists on DC functions is not well defined. The aim of the present study was to examine the effect of epinastine hydrochloride (EP), the most notable histamine H1 receptor antagonists in Japan, on Dermatophagoides farinae (Der f)-pulsed mouse bone marrow-derived DCs in vitro and in vivo. EP at more than 25 ng/mL could significantly inhibit the production of IL-6, TNF-α and IL-10 from Der f-pulsed DCs, which was increased by Der f challenge in vitro. On the other hand, EP increased the ability of Der f-pulsed DCs to produce IL-12. Intranasal instillation of Der f-pulsed DCs resulted in nasal eosinophilia associated with a significant increase in IL-5 levels in nasal lavage fluids. Der f-pulsed and EP-treated DCs significantly inhibited nasal eosinophila and reduced IL-5. These results indicate that EP inhibits the development of Th2 immune responses through the modulation of DC functions and results in favorable modification of clinical status of allergic diseases.
机译:已确立的概念是树突状细胞(DC)在过敏性免疫反应的发展中起重要作用。但是,H1受体拮抗剂对DC功能的影响尚不明确。本研究的目的是在体外和体内研究吡喃苯丙氨酸盐酸盐(EP)(日本最著名的组胺H1受体拮抗剂)对粉状皮肤癣菌(Der f)刺激的小鼠骨髓DC的作用。超过25 ng / mL的EP可以显着抑制Der f脉冲DC产生IL-6,TNF-α和IL-10,而Der f体外刺激可增加这些产生。另一方面,EP增加了Der f脉冲DC产生IL-12的能力。鼻内滴注Der f脉冲DC会导致鼻嗜酸性粒细胞增多,并与鼻灌洗液中IL-5水平的显着增加有关。 Der f脉冲和EP处理的DC显着抑制鼻嗜酸性粒细胞并降低IL-5。这些结果表明,EP通过调节DC功能来抑制Th2免疫应答的发展,并导致过敏性疾病的临床状况得到良好的改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号